Last --
Change Today 0.00 / 0.00%
Volume 0.0
4548 On Other Exchanges
Symbol
Exchange
4548 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

seikagaku corp (4548) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SEIKAGAKU CORP (4548)

Related News

No related news articles were found.

seikagaku corp (4548) Related Businessweek News

No Related Businessweek News Found

seikagaku corp (4548) Details

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan. The company operates through Pharmaceutical and LAL segments. It offers pharmaceuticals and medical devices, such as intra-articular injections for improving joint functions under the brand names of ARTZ, ARTZ Dispo, SUPARTZ, ARTZAL, etc.; an injection medical device for treatment of osteoarthritis pain of the knee under the brand name of Gel-One; OPEGAN branded ophthalmic surgical aids; and MucoUp branded surgical aid for endoscopic mucosal resection. The company also provides bulk products consisting of hyaluronic acid, which is primarily used as a raw material of joint function improving agents, ophthalmic surgical aids, and ophthalmic products; and chondroitin sulfate that is used as a raw material in ophthalmic products comprising eye drops and eyewashes, drinks for nutritional fortifications, etc. In addition, it develops endotoxin-detecting reagents under various brands, including the Pyrochrome, ENDOSPECY, TOXICOLOR, etc. for quality control in the manufacturing process and release test of pharmaceuticals and medical devices, as well as dialysis fluid. Further, Seikagaku Corporation develops and markets oral care products comprising mouthwash under the KINUSUI Spray brand. It also exports its products to various countries. The company was formerly known as K.K. Seikagaku Kenkyusho and changed its name to Seikagaku Corporation in 1962. Seikagaku Corporation was founded in 1947 and is headquartered in Tokyo, Japan.

639 Employees
Last Reported Date: 06/24/14
Founded in 1947

seikagaku corp (4548) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

seikagaku corp (4548) Key Developments

Seikagaku Corporation Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2014; Provides Dividend Guidance for the Year Ending March 31, 2015; Provides Earnings Guidance for the Year Ending March 31, 2015

Seikagaku Corporation reported consolidated earnings results for the nine months ended December 31, 2014. The company reported net sales of ¥22,075 million compared with ¥23,122 million for the same period last year. Operating income was ¥2,273 million compared with ¥4,975 million for the same period last year. Ordinary income was ¥3,787 million compared with ¥5,723 million for the same period last year. Net income was ¥3,042 million or ¥53.56 per share compared with ¥4,652 million or ¥81.90 per share for the same period last year. Net sales fell 4.5% year on year, this is attributable to factors including National Health Insurance (NHI) drug price reductions in Japan and a decline in shipments to overseas sales partners from a relatively high level shipment in the first nine months of fiscal 2013, despite the positive impact of yen depreciation. For the fiscal year ending March 31, 2015, the company expects year end dividend of ¥13.00 per share against ¥13.00 per share paid for the same period a year ago. For the fiscal year ending March 31, 2015, the company expects net sales of ¥29,150 million, operating income of ¥2,750 million, ordinary income of ¥4,200 million and net income of ¥3,450 million or ¥60.73 per share.

Seikagaku Corp. to Report Q3, 2015 Results on Feb 03, 2015

Seikagaku Corp. announced that they will report Q3, 2015 results at 3:00 PM, Tokyo Standard Time on Feb 03, 2015

Seikagaku Corporation Reports Consolidated Earnings Results for the Six Months Ended September 30, 2014; Provides Earnings Guidance for the Fiscal Year 2014; Declares Dividend for the Second Quarter of 2014; Provides Dividend Guidance for the Fiscal Year 2014

Seikagaku Corporation reported consolidated earnings results for the six months ended September 30, 2014. For the period, the company reported that net sales of JPY 14,247 million against JPY 15,405 million a year ago. Operating income was JPY 1,564 million against JPY 3,488 million a year ago. Ordinary income was JPY 2,109 million against JPY 3,783 million a year ago. Net income was JPY 1,687 million or JPY 29.71 per share against JPY 3,118 million or JPY 54.90 per share a year ago. In the first six months of the fiscal year ending March 31, 2015, net sales fell 7.5%, this is attributable to factors including National Health Insurance (NHI) drug price reductions in Japan and a decline in shipments to overseas sales partners arising from a relatively high shipment level in the first six months of fiscal 2013, despite increase of net sales due to the impact of yen depreciation. For the second quarter of 2014, the company declared a dividend of JPY 13.00 per share. For the fiscal year 2014, the company expects to pay a dividend of JPY 13.00 per share. For fiscal 2014, the company expects net sales of JPY 29,150 million, operating income of JPY 2,750 million, ordinary income of JPY 4,200 million and net income of JPY 3,450 million, or JPY 60.73 per share.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4548:JP ¥2,005.00 JPY -14.00

4548 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Zimmer Holdings Inc $120.39 USD -0.94
View Industry Companies
 

Industry Analysis

4548

Industry Average

Valuation 4548 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEIKAGAKU CORP, please visit www.seikagaku.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.